Beyond-use date (revision 10)
Old revision·14:23, 10 Nov 2024·ArchiveBot
| Beyond-use date | |
|---|---|
| Abbreviation | BUD |
| Assigned by | The compounder or the person opening the container |
| Basis | Compendial default tables, or product-specific testing |
| Contrast | Expiration date, assigned by the manufacturer from stability data |
| Topic infobox · conventions | |
A beyond-use date (BUD) is the date, or date and time, after which a compounded preparation or an opened container is not to be used. It is assigned by the person who prepares or opens the preparation, using compendial default tables or, where available, testing specific to the preparation. It is distinct from an expiration date, which is assigned by a manufacturer on the basis of a formal stability programme conducted on the finished product in its final container.[1][2]
The distinction is one of evidence rather than of vocabulary. An expiration date rests on long-term, intermediate and accelerated stability studies conducted under the conditions specified in ICH Q1A(R2), analysed statistically, and submitted to a regulator; it is a claim about the specific product in the specific container. A beyond-use date generally rests on a table of conservative defaults chosen to be safe across a wide range of preparations, and it is a claim about a class of preparations rather than about the one in hand. The two are therefore not comparable quantities, and a short beyond-use date does not imply a preparation degrades quickly.[3][1]
Beyond-use dates in sterile compounding are limited principally by microbiological risk rather than by chemical degradation. The default periods in USP <797> are graduated by how the preparation was made, by whether sterility testing was performed and passed, and by storage temperature — not by the chemistry of the active substance. Chemical stability is a separate constraint, and where it is shorter it governs.[1]
Definition and contrast with the expiration date
[edit]An expiration date is the output of a defined regulatory process. Under ICH Q1A(R2), a manufacturer conducts long-term studies at the intended storage condition, intermediate studies where required, and accelerated studies at elevated temperature and humidity, on at least three primary batches in the container closure system intended for marketing. The results are evaluated — under ICH Q1E — to establish a retest period or shelf life, and the date is stated on the label. It applies to the unopened product stored as labelled.[3]
A beyond-use date has none of that apparatus behind it. It applies to a preparation that the manufacturer's stability programme never examined: a container that has been opened, a solution that has been diluted, a lyophilised solid that has been reconstituted, or a preparation compounded from components. The chemistry may be identical; the container's history is not.
| !Property | Expiration date | Beyond-use date |
|---|---|---|
| Assigned by | Manufacturer | Compounder or dispenser |
| Evidence base | Product-specific stability programme | Compendial default table, or preparation-specific testing |
| Applies to | Unopened product, stored as labelled | Compounded or opened preparation |
| Principal limiting factor | Chemical and physical degradation | Microbiological risk, then chemical stability |
| Regulatory status | Submitted and approved | Assigned under a compendial standard |
| Typical magnitude | 12–60 months | Hours to 180 days |
References
- ^ a b c United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations", 2023 revision, including the beyond-use date tables for Category 1, 2 and 3 preparations.
- ^ United States Pharmacopeia, General Chapter <1191>, "Stability Considerations in Dispensing Practice" (informational). USP–NF, current revision.
- ^ a b International Council for Harmonisation, Q1A(R2): Stability Testing of New Drug Substances and Products (2003), read with Q1E: Evaluation for Stability Data (2003).